Kura Oncology, Inc. (KURA)
9.37
+0.16
(+1.74%)
USD |
NASDAQ |
Jan 14, 16:00
9.32
-0.05
(-0.53%)
After-Hours: 19:15
Kura Oncology Total Liabilities (Quarterly): 406.84M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 11.57M |
| Perspective Therapeutics, Inc. | 52.61M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Electromed, Inc. | 8.869M |
| Armata Pharmaceuticals, Inc. | 185.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 649.38M |
| Shareholders Equity (Quarterly) | 242.54M |
| Debt to Equity Ratio | 0.0803 |
| Current Ratio | 5.117 |
| Net Debt Paydown Yield | -0.07% |